Biomedican | Dennis O’Neill

Share on facebook
Share on twitter
Share on linkedin
Share on email

Trace cannabinoids; what’s beyond THC and CBD?

Despite the known benefits of the lesser known cannabis cannabinoid; their small percentage within the plant make it cost prohibitive to extract meaningful quantity.   Dennis O’Neill the President of Biomedican joins Dan Humiston to explain how their patented process helps them produce high quantities of high quality, organic trace cannabinoids.   He discusses their current equity crowdfunding campaign on  WeFunder and how to invest in their company’s growth.

Produced by PodCONX

Raising Cannabis Capital -

Dan Humiston –

Dennis O’Neill –

Biomedican -

WeFunder -

View original source video by clicking here

On Key

Related Posts

Drs. Investigate: Are You Getting Fake CBD Products?

Doctors’ senior investigative producer Leslie Marcus uncovers an unscrupulous marketplace for the cannabis compound CBD that may be cashing in on unsuspecting consumers. Subscribe to The Doctors: Like us on Facebook: Follow us on Twitter: Follow us on Instagram: Follow us on Pinterest: About The Doctors: The Doctors is an…